BACKGROUND: Progressive familial heart block type I (PFHBI) is a hereditary arrhythmia characterized by progressive conduction disturbances in the His-Purkinje system. PFHBI has been linked to genes such as SCN5A that influence cardiac excitability but not to genes that influence cell-to-cell communication. Our goal was to explore whether nucleotide substitutions in genes coding for connexin proteins would associate with clinical cases of PFHBI and if so, to establish a genotype-cell phenotype correlation for that mutation. METHODS AND RESULTS: We screened 156 probands with PFHBI. In addition to 12 sodium channel mutations, we found a germ line GJA5 (connexin40 [Cx40]) mutation (Q58L) in 1 family. Heterologous expression of Cx40-Q58L in connexin-deficient neuroblastoma cells resulted in marked reduction of junctional conductance (Cx40-wild type [WT], 22.2±1.7 nS, n=14; Cx40-Q58L, 0.56±0.34 nS, n=14; P<0.001) and diffuse localization of immunoreactive proteins in the vicinity of the plasma membrane without formation of gap junctions. Heteromeric cotransfection of Cx40-WT and Cx40-Q58L resulted in homogenous distribution of proteins in the plasma membrane rather than in membrane plaques in ≈50% of cells; well-defined gap junctions were observed in other cells. Junctional conductance values correlated with the distribution of gap junction plaques. CONCLUSIONS: Mutation Cx40-Q58L impairs gap junction formation at cell-cell interfaces. This is the first demonstration of a germ line mutation in a connexin gene that associates with inherited ventricular arrhythmias and emphasizes the importance of Cx40 in normal propagation in the specialized conduction system.
BACKGROUND: Progressive familial heart block type I (PFHBI) is a hereditary arrhythmia characterized by progressive conduction disturbances in the His-Purkinje system. PFHBI has been linked to genes such as SCN5A that influence cardiac excitability but not to genes that influence cell-to-cell communication. Our goal was to explore whether nucleotide substitutions in genes coding for connexin proteins would associate with clinical cases of PFHBI and if so, to establish a genotype-cell phenotype correlation for that mutation. METHODS AND RESULTS: We screened 156 probands with PFHBI. In addition to 12 sodium channel mutations, we found a germ line GJA5 (connexin40 [Cx40]) mutation (Q58L) in 1 family. Heterologous expression of Cx40-Q58L in connexin-deficient neuroblastoma cells resulted in marked reduction of junctional conductance (Cx40-wild type [WT], 22.2±1.7 nS, n=14; Cx40-Q58L, 0.56±0.34 nS, n=14; P<0.001) and diffuse localization of immunoreactive proteins in the vicinity of the plasma membrane without formation of gap junctions. Heteromeric cotransfection of Cx40-WT and Cx40-Q58L resulted in homogenous distribution of proteins in the plasma membrane rather than in membrane plaques in ≈50% of cells; well-defined gap junctions were observed in other cells. Junctional conductance values correlated with the distribution of gap junction plaques. CONCLUSIONS: Mutation Cx40-Q58L impairs gap junction formation at cell-cell interfaces. This is the first demonstration of a germ line mutation in a connexin gene that associates with inherited ventricular arrhythmias and emphasizes the importance of Cx40 in normal propagation in the specialized conduction system.
Authors: J J Schott; C Alshinawi; F Kyndt; V Probst; T M Hoorntje; M Hulsbeek; A A Wilde; D Escande; M M Mannens; H Le Marec Journal: Nat Genet Date: 1999-09 Impact factor: 38.330
Authors: Anne Royer; Toon A B van Veen; Sabrina Le Bouter; Céline Marionneau; Violaine Griol-Charhbili; Anne-Laure Léoni; Marja Steenman; Harold V M van Rijen; Sophie Demolombe; Catharine A Goddard; Christine Richer; Brigitte Escoubet; Thérèse Jarry-Guichard; William H Colledge; Daniel Gros; Jacques M T de Bakker; Andrew A Grace; Denis Escande; Flavien Charpentier Journal: Circulation Date: 2005-04-04 Impact factor: 29.690
Authors: A de Meeus; E Stephan; S Debrus; M K Jean; J Loiselet; J Weissenbach; J Demaille; P Bouvagnet Journal: Circ Res Date: 1995-10 Impact factor: 17.367
Authors: Lucile Miquerol; Sonia Meysen; Matteo Mangoni; Patrick Bois; Harold V M van Rijen; Patrice Abran; Habo Jongsma; Joël Nargeot; Daniel Gros Journal: Cardiovasc Res Date: 2004-07-01 Impact factor: 10.787
Authors: William P McNair; Lisa Ku; Matthew R G Taylor; Pam R Fain; Dmi Dao; Eugene Wolfel; Luisa Mestroni Journal: Circulation Date: 2004-10-04 Impact factor: 29.690
Authors: Daniel J Chaston; Rebecca E Haddock; Lauren Howitt; Susan K Morton; Russell D Brown; Klaus I Matthaei; Caryl E Hill Journal: Pflugers Arch Date: 2014-11-05 Impact factor: 3.657
Authors: Barbara Ströh van Deventer; Lorraine du Toit-Prinsloo; Chantal van Niekerk Journal: Forensic Sci Med Pathol Date: 2018-06-16 Impact factor: 2.007
Authors: Laura E Murray; Andrew H Smith; English C Flack; Kim Crum; Jill Owen; Prince J Kannankeril Journal: Heart Rhythm Date: 2016-11-05 Impact factor: 6.343
Authors: Jay D Pruetz; Jennifer C Miller; Gerald E Loeb; Michael J Silka; Yaniv Bar-Cohen; Ramen H Chmait Journal: Birth Defects Res Date: 2019-03-01 Impact factor: 2.344
Authors: Luc Leybaert; Paul D Lampe; Stefan Dhein; Brenda R Kwak; Peter Ferdinandy; Eric C Beyer; Dale W Laird; Christian C Naus; Colin R Green; Rainer Schulz Journal: Pharmacol Rev Date: 2017-10 Impact factor: 25.468
Authors: Mary E Haywood; Andrea Cocciolo; Kadijah F Porter; Evgenia Dobrinskikh; Dobromir Slavov; Sharon L Graw; T Brett Reece; Amrut V Ambardekar; Michael R Bristow; Luisa Mestroni; Matthew R G Taylor Journal: J Mol Cell Cardiol Date: 2020-01-18 Impact factor: 5.000